Transcend Capital Advisors, LLC Abb Vie Inc. Transaction History

Transcend Capital Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 46,363 shares of ABBV stock, worth $8.17 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

46,363

Previous 46,227 0.29%

Holding current value

$8.17 Million

Previous $7.93 Million 15.48%

% of portfolio

0.63%

Previous 0.59%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$163.84 - $199.33 $22,282 - $27,108	136 Added 0.29%	46,363 $9.16 Million
Q2 2024 Jul 02, 2024	BUY	$154.79 - $180.76 $2.72 Million - $3.17 Million	17,559 Added 61.25%	46,227 $7.93 Million
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $1.08 Million - $1.23 Million	6,775 Added 30.95%	28,668 $5.22 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $35,225 - $39,672	-256 Reduced 1.16%	21,893 $3.39 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $32,863 - $38,043	-246 Reduced 1.1%	22,149 $3.3 Million
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $44,920 - $55,901	339 Added 1.54%	22,395 $3.02 Million
Q1 2023 Apr 12, 2023	SELL	$144.61 - $166.54 $60,013 - $69,114	-415 Reduced 1.85%	22,056 $3.52 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $90,454 - $108,478	-654 Reduced 2.83%	22,471 $0
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $17,715 - $20,318	132 Added 0.57%	23,125 $3.1 Million
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $47,203 - $60,011	-343 Reduced 1.47%	22,993 $3.52 Million
Q1 2022 Apr 20, 2022	BUY	$131.98 - $163.75 $107,299 - $133,128	813 Added 3.61%	23,336 $3.78 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $66,928 - $84,684	623 Added 2.84%	22,523 $3.05 Million
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $279,406 - $317,168	2,626 Added 13.62%	21,900 $2.4 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $150,450 - $167,610	1,430 Added 8.01%	19,274 $2.17 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $62,096 - $68,360	-607 Reduced 3.29%	17,844 $1.94 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $230,040 - $310,578	2,858 Added 18.33%	18,451 $1.98 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $106,528 - $125,029	1,240 Added 8.64%	15,593 $1.37 Million
Q2 2020 Aug 05, 2020	SELL	$73.37 - $98.18 $256,354 - $343,040	-3,494 Reduced 19.58%	14,353 $1.41 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $54,309 - $82,339	-842 Reduced 4.51%	17,847 $1.36 Million
Q4 2019 Feb 19, 2020	BUY	$72.13 - $90.25 $1.35 Million - $1.69 Million	18,689 New	18,689 $1.66 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Abb Vie Inc. Transaction History